tiprankstipranks
Theriva Biologics (TOVX)
XASE:TOVX
US Market
TOVX
Theriva Biologics
RESEARCH TOOLSreports
Want to see TOVX full AI Analyst Report?

Theriva Biologics (TOVX) Income Statement

1,242 Followers

Theriva Biologics Income Statement

Last quarter (Q4 2025), Theriva Biologics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Theriva Biologics's net income was $-3.51M. See Theriva Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -108.00K$ 0.00$ 0.00$ 0.00$ -87.00K
Operating Expenses
$ 14.91M$ 26.35M$ 21.43M$ 21.58M$ 14.27M
Depreciation and Amortization
$ 108.00K$ 137.00K$ 135.00K$ 85.00K$ 87.00K
EBITDA
$ -14.91M$ -19.29M$ -21.96M$ -19.20M$ -14.19M
Operating Income
$ -15.02M$ -26.35M$ -21.43M$ -21.58M$ -14.27M
Other Income/Expenses
$ -8.72M$ 693.00K$ 1.44M$ 471.00K$ 6.00K
Pretax Income
$ -23.74M$ -25.65M$ -19.99M$ -21.11M$ -14.27M
Net Income
$ -25.25M$ -25.65M$ -18.35M$ -19.68M$ -14.27M
Per Share Metrics
Basic EPS
$ -2.08$ -19.03$ -28.49$ -32.66$ -1.90
Diluted EPS
$ -2.08$ -19.03$ -28.48$ -32.66$ -1.90
Weighted Average Shares Outstanding
 12.14M 1.35M 644.00K 613.09K 12.19M
Weighted Average Shares Outstanding (Diluted)
 12.14M 1.35M 644.28K 613.09K 12.19M
Currency in USD

Theriva Biologics Earnings and Revenue History